Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Pancreatic Cancer Metastatic × folfirinox × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 18 Neoplasms 5 Neoplasm Metastasis 2 Urachal cancer 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Pancreatic Cancer Metastatic 1 Gastro-enteropancreatic neuroendocrine tumor 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Cholangiocarcinoma 1 Carcinoma, Pancreatic Ductal 1 Carcinoma, Islet Cell 1 Carcinoma, Hepatocellular 1 Borderline Resectable Pancreatic Cancer 1 Biliary Tract Neoplasms 1 Adenocarcinoma 1

Interventions

surufatinib 1 folfirinox 1 Oxaliplatin 1 Irinotecan 1 Immune Checkpoint Inhibitors 1 Gemcitabine 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04469556 2026-02-20

PASS-01

University Health Network, Toronto

Phase 2 Completed

Gastrointestinal

Pancreatic Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡